Literature DB >> 15688178

[Splenectomy for thrombocytopenic purpura. Retrospective analysis of the postoperative course].

K Beseoglu1, U Germing, W Gross-Weege.   

Abstract

BACKGROUND: Idiopathic thrombocytopenic purpura (ITP) comprises approximately 8% of all haemorrhagic diseases. Typical findings are a very low platelet count which manifests as petechial bleeding. Therapy consists of medication and removal of the spleen if conservative therapy fails. PATIENTS AND METHODS: Between 1988 and 1999, 47 patients with ITP were splenectomized in our surgical department. We examine the postoperative development of platelet counts and long-term results in 33 of these patients.
RESULTS: After splenectomy, more then 75% of our patients had normal platelet counts. In long-term examination, 58% remained in stable condition with normal platelet counts. Retrospectively we tried to identify preoperative clinical features that could predict the long-term outcome of splenectomy in ITP but were unable to find reliable factors.
CONCLUSION: Idiopathic thrombocytopenic purpura can be treated by surgical means but should be considered only when conservative treatment has failed. The long-term outcome of splenectomy is not predictable. Reliable predictive factors have to be identified through further research.

Entities:  

Mesh:

Year:  2005        PMID: 15688178     DOI: 10.1007/s00104-004-0998-2

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  26 in total

1.  Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy.

Authors:  M G Mazzucconi; M C Arista; M Peraino; A Chistolini; C Felici; V Francavilla; E Macale; L Conti; G M Gandolfo
Journal:  Eur J Haematol       Date:  1999-04       Impact factor: 2.997

2.  Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura.

Authors:  N Katkhouda; S W Grant; E Mavor; M H Friedlander; R V Lord; K Achanta; R Essani; R Mason
Journal:  Surg Endosc       Date:  2001-02-06       Impact factor: 4.584

3.  Long-term outcome of splenectomy for immune thrombocytopenic purpura.

Authors:  K Maślanka; A Sikorska; A Misiak; L Konopka; B Zupańska
Journal:  Am J Hematol       Date:  2004-02       Impact factor: 10.047

4.  Prevention and management of infections in patients without a spleen.

Authors:  R N Davidson; R A Wall
Journal:  Clin Microbiol Infect       Date:  2001-12       Impact factor: 8.067

Review 5.  Palliative splenectomy in myelofibrosis with myeloid metaplasia.

Authors:  R A Mesa; A Tefferi
Journal:  Leuk Lymphoma       Date:  2001 Sep-Oct

Review 6.  Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update.

Authors:  R Yang; Z C Han
Journal:  Int J Hematol       Date:  2000-01       Impact factor: 2.490

7.  Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis.

Authors:  J Pizzuto; R Ambriz
Journal:  Blood       Date:  1984-12       Impact factor: 22.113

8.  Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group.

Authors:  D Ben-Yehuda; S Gillis; A Eldor
Journal:  Acta Haematol       Date:  1994       Impact factor: 2.195

9.  Laparoscopic splenectomy for idiopathic thrombocytopenic purpura.

Authors:  Bernard Delaitre; Eric Blezel; Guy Samama; Christophe Barrat; Dominique Gossot; Laurent Bresler; Christian Meyer; Bernard Heyd; Denis Collet; Gérard Champault
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2002-12       Impact factor: 1.719

10.  Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura.

Authors:  Derick Holt; Justin Brown; Kelly Terrill; Robert Goldsby; Rebecka L Meyers; Jody Heximer; Beth Nordfors; William B Slayton
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.